Rush University Medical Center


 

Hodgkin Lymphoma: Managing Brentuximab Vedotin/CPI Dual Refractory Patients

11 views
May 27, 2022
0 Comments
Login to view comments. Click here to Login
2nd Midwest Cellular Conference: Treatment Options for Advanced Hematologic Malignancies